NASOPHARYNGEAL CARCINOMA
Clinical trials for NASOPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Threat attack on advanced throat cancer enters testing
Disease control Recruiting nowThis study is testing whether adding two drugs, envafolimab and endostatin, to standard chemotherapy and radiation works better for people with locally advanced nasopharyngeal cancer. It will involve about 30 patients who have not had prior treatment. The goal is to see if this c…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Chongqing University Cancer Hospital • Aim: Disease control
Last updated Apr 04, 2026 03:36 UTC
-
Two-Pronged attack on advanced cancers shows promise
Disease control Recruiting nowThis study is testing whether combining two different cancer drugs (BL-B01D1 and a PD-1 antibody) works better than current treatments for people with advanced lung cancer, nasopharyngeal cancer, or other solid tumors that have spread. Researchers will enroll 570 patients to see …
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New hope for advanced throat cancer: triple therapy trial seeks better control
Disease control Recruiting nowThis study is testing whether adding low-dose radiation and an immunotherapy drug to standard chemotherapy and radiation works better for advanced nasopharyngeal cancer. Researchers will compare the new combination approach against current standard treatment in 380 patients. The …
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Smarter radiation aims to spare patients harsh side effects
Disease control Recruiting nowThis study is testing a more targeted approach to radiation therapy for nasopharyngeal cancer. It aims to see if focusing radiation only on specific areas of the neck, based on detailed scans, can reduce side effects like thyroid problems and swallowing issues while keeping cance…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Three-Pronged attack: new combo therapy aims to wipe out advanced throat cancer
Disease control Recruiting nowThis study is testing a new three-drug combination (gemcitabine, docetaxel, and toripalimab) given before standard radiation therapy for people with a specific type of advanced throat cancer (EBV-positive nasopharyngeal carcinoma). The goal is to see if this approach is safe, fea…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo targets tough cancers in major trial
Disease control Recruiting nowThis study is testing a new two-drug combination (BL-B01D1 + SI-B003) for people with advanced lung cancer or throat cancer that has spread. The main goals are to see if the treatment can shrink tumors and to determine the safest and most effective dose. It will involve about 121…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Can less radiation be just as effective for throat cancer?
Disease control Recruiting nowThis study is for people with a specific intermediate-stage nasopharyngeal (upper throat) cancer that has responded well to initial drug treatment. It compares a lower dose of radiation to the standard dose, both given alongside immunotherapy. The goal is to see if the lower dose…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Ming-Yuan Chen • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Cancer trial aims to cut radiation side effects without losing effectiveness
Disease control Recruiting nowThis study is testing whether a lower dose of radiation therapy works as well as the standard dose for certain patients with stage III nasopharyngeal cancer (a type of head and neck cancer). It will enroll about 593 patients in China who respond well to initial chemotherapy and i…
Matched conditions: NASOPHARYNGEAL CARCINOMA
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC